Insider Transactions in Q2 2023 at 89bio, Inc. (ETNB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-2.66%
|
$51,876
$18.95 P/Share
|
|
Jun 30
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+7.14%
|
-
|
|
Jun 30
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-1.66%
|
$51,876
$18.95 P/Share
|
|
Jun 30
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+4.59%
|
-
|
|
Jun 30
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-3.4%
|
$36,324
$18.95 P/Share
|
|
Jun 30
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,834
+8.94%
|
-
|
|
Jun 30
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,527
-5.13%
|
$297,486
$18.95 P/Share
|
|
Jun 30
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,334
+9.38%
|
-
|
|
Jun 05
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.97%
|
$300,000
$20.0 P/Share
|
|
Jun 05
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+4.73%
|
$15,000
$1.93 P/Share
|
|
Jun 01
2023
|
Edward Morrow Atkinson Iii |
SELL
Open market or private sale
|
Direct |
6,250
-100.0%
|
$106,250
$17.91 P/Share
|
|
Jun 01
2023
|
Edward Morrow Atkinson Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$12,500
$2.61 P/Share
|
|
May 09
2023
|
Quoc Le Nguyen |
SELL
Open market or private sale
|
Direct |
13,683
-7.66%
|
$246,294
$18.11 P/Share
|
|
May 09
2023
|
Quoc Le Nguyen |
BUY
Exercise of conversion of derivative security
|
Direct |
79,571
+18.51%
|
$238,713
$3.11 P/Share
|
|
Apr 04
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,721
-14.0%
|
$122,094
$14.95 P/Share
|